Elisabeth Heath, M.D.
Barbara Ann Karmanos Institute · Barbara Ann Karmanos Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Elisabeth Heath, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:23 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04159896 · ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate CancerBarbara Ann Karmanos Cancer Institute · terminated · Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma · principal investigator
- Ph2NCT02058706 · LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate CancerBarbara Ann Karmanos Cancer Institute · completed · Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Research Training and Education CoordinationP30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Morhaf Al Achkar · fiscal years 1997 to 2026Named on NCT04159896, NCT02058706
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.